Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital

被引:121
作者
Dent, Lemuel L. [1 ]
Marshall, Dana R. [1 ]
Pratap, Siddharth
Hulette, Robert B. [2 ]
机构
[1] Meharry Med Coll, Dept Surg, Nashville, TN 37208 USA
[2] Nashville Gen Hosp, Dept Infect Control, Nashville, TN USA
关键词
VENTILATOR-ASSOCIATED PNEUMONIA; RISK-FACTORS; ATTRIBUTABLE MORTALITY; INFECTIONS; PREVALENCE;
D O I
10.1186/1471-2334-10-196
中图分类号
R51 [传染病];
学科分类号
100201 [内科学];
摘要
Background: Multidrug resistant Acinetobacter baumannii, (MRAB) is an important cause of hospital acquired infection. The purpose of this study is to determine the risk factors for MRAB in a city hospital patient population. Methods: This study is a retrospective review of a city hospital epidemiology data base and includes 247 isolates of Acinetobacter baumannii (AB) from 164 patients. Multidrug resistant Acinetobacter baumannii was defined as resistance to more than three classes of antibiotics. Using the non-MRAB isolates as the control group, the risk factors for the acquisition of MRAB were determined. Results: Of the 247 AB isolates 72% (177) were multidrug resistant. Fifty-eight percent (143/247) of isolates were highly resistant (resistant to imipenem, amikacin, and ampicillin-sulbactam). Of the 37 patients who died with Acinetobacter colonization/infection, 32 (86%) patients had the organism recovered from the respiratory tract. The factors which were found to be significantly associated (p <= 0.05) with multidrug resistance include the recovery of AB from multiple sites, mechanical ventilation, previous antibiotic exposure, and the presence of neurologic impairment. Multidrug resistant Acinetobacter was associated with significant mortality when compared with sensitive strains (p <= 0.01). When surgical patients (N = 75) were considered separately, mechanical ventilation and multiple isolates remained the factors significantly associated with the development of multidrug resistant Acinetobacter. Among surgical patients 46/75 (61%) grew a multidrug resistant strain of AB and 37/75 (40%) were resistant to all commonly used antibiotics including aminoglycosides, cephalosporins, carbepenems, extended spectrum penicillins, and quinolones. Thirty-five percent of the surgical patients had AB cultured from multiple sites and 57% of the Acinetobacter isolates were associated with a co-infecting organism, usually a Staphylococcus or Pseudomonas. As in medical patients, the isolation of Acinetobacter from multiple sites and the need for mechanical ventilation were significantly associated with the development of MRAB. Conclusions: The factors significantly associated with MRAB in both the general patient population and surgical patients were mechanical ventilation and the recovery of Acinetobacter from multiple anatomic sites. Previous antibiotic use and neurologic impairment were significant factors in medical patients. Colonization or infection with MRAB is associated with increased mortality.
引用
收藏
页数:7
相关论文
共 19 条
[1]
Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections [J].
Baran, Guelseren ;
Erbay, Ayse ;
Bodur, Huerrem ;
Onguru, Pinar ;
Akinci, Esraguel ;
Balaban, Neriman ;
Cevik, Mustafa A. .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 (01) :16-21
[2]
Ventilator-associated pneumonia [J].
Chastre, J ;
Fagon, JY .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (07) :867-903
[3]
Multidrug-resistant Acinetobacter extremity infections in soldiers [J].
Davis, KA ;
Moran, KA ;
McAllister, CK ;
Gray, PJ .
EMERGING INFECTIOUS DISEASES, 2005, 11 (08) :1218-1224
[4]
Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa:: a systematic review of the literature [J].
Falagas, M. E. ;
Kopterides, P. .
JOURNAL OF HOSPITAL INFECTION, 2006, 64 (01) :7-15
[5]
Attributable mortality of Acinetobacter baumannii:: no longer a controversial issue [J].
Falagas, Matthew E. ;
Rafailidis, Petros I. .
CRITICAL CARE, 2007, 11 (03)
[6]
The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa [J].
Falagas, Matthew E. ;
Koletsi, Patra K. ;
Bliziotis, Ioannis A. .
JOURNAL OF MEDICAL MICROBIOLOGY, 2006, 55 (12) :1619-1629
[7]
Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients [J].
García-Garmendia, JL ;
Ortiz-Leyba, C ;
Garnacho-Montero, J ;
Jiménez-Jiménez, FJ ;
Monterrubio-Villar, J ;
Gili-Miner, M .
CRITICAL CARE MEDICINE, 1999, 27 (09) :1794-1799
[8]
Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin:: A comparison with imipenem-susceptible VAP [J].
Garnacho-Montero, J ;
Ortiz-Leyba, C ;
Jiménez-Jiménez, FJ ;
Barrero-Alodóvar, AE ;
García-Garmendia, JL ;
Bernabeu-Witteli, M ;
Gallego-Lara, SL ;
Madrazo-Osuna, J .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (09) :1111-1118
[9]
Jamulitrat Silom, 2009, Journal of the Medical Association of Thailand, V92, P413
[10]
Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO) [J].
Kluytmans-VandenBergh, MFQ ;
Kluytmans, JAJW ;
Voss, A .
INFECTION, 2005, 33 (5-6) :309-313